Omeros Corporation (OMER)
NASDAQ: OMER · Real-Time Price · USD
6.18
-0.13 (-2.06%)
At close: May 9, 2025, 4:00 PM
6.10
-0.08 (-1.29%)
After-hours: May 9, 2025, 4:06 PM EDT
Omeros Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
202
Market Cap
358.83M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
OMER News
- 3 days ago - FDA Accepts Resubmission of BLA for Narsoplimab for Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy (TA-TMA) and Assigns Late September PDUFA Date - Business Wire
- 4 weeks ago - Omeros' New Leukemia Drug Team Ignites Hope For Cancer Fight - Benzinga
- 4 weeks ago - Omeros Announces the Omeros Oncology Clinical Steering Committee for AML to Help Guide Omeros' Proprietary OncotoX-AML Clinical Program - Business Wire
- 4 weeks ago - Omeros Corporation To Introduce Its Proprietary T-CAT™ Program for the Treatment of Multidrug-Resistant Pathogens in Plenary Session at Upcoming European Congress on Infectious Diseases - Business Wire
- 5 weeks ago - Omeros Corporation (OMER) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Omeros Corporation Reports Fourth Quarter and Year-End 2024 Financial Results - Business Wire
- 6 weeks ago - Top Wall Street Forecasters Revamp Omeros Price Expectations Ahead Of Q4 Earnings - Benzinga
- 6 weeks ago - Omeros Corporation to Announce Fourth Quarter and Year-end Financial Results on March 31, 2025 - Business Wire